Sabinsa Secures Patent for Bioperine in Canada
In addition to securing a patent for Bioperine in Canada, Sabinsa Corporation's U.S. Patent 5,972,382 for Bioperine received a formal review from the US Patent and Trademark Office, which concluded that all points outlined were valid.
07/08/07 Sabinsa Corporation has secured a patent in Canada for its branded ingredient Bioperine, a standardized piperine composition derived from black pepper extract. Patent #2,247,467 protects the use of piperine as a bioavailability enhancer and affirms that Bioperine is the only black pepper extract that can legally be used in nutritional supplements for the purpose of enhancing the bioavailability of nutrients in Canada.
"The Canadian patent for Bioperine represents over 10 years of concerted and sustained effort, and we are particularly pleased with the successful outcome," stated Vladimir Badmaev, M.D., Ph.D., vice president of scientific and medical affairs, Sabinsa Corporation. "With a Japanese patent recently secured and U.S. and European patents in place, we continue our efforts to protect the clinically tested benefits of our invention against potential infringement."
In addition to securing a patent for Bioperine in Canada, Sabinsa Corporation's U.S. Patent 5,972,382 for Bioperine received a formal review from the US Patent and Trademark Office (USPTO), which concluded that all points outlined were valid for "Use of piperine as a bioavailability enhancer."
